Zobrazeno 1 - 10
of 264
pro vyhledávání: '"Xiang‐ping Li"'
Autor:
Juan Chen, Jun-yan Liu, Fan Yang, Ting Zou, Zhan Wang, Jia-Si Liu, Lei She, Xiang-Ping Li, Zhaoqian Liu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Metabolomics has the characteristics of terminal effects and reflects the physiological state of biological diseases more directly. Several current biomarkers of multiple omics were revealed to be associated with immune-related adverse eve
Externí odkaz:
https://doaj.org/article/e859f974f18143f583d04df53a0dd5ed
Autor:
Zhe Xu, Zhuo‐miao Ye, Yu‐kai Tang, Dong‐feng Deng, Qin Zhou, Man Fang, Ying‐ying Zhang, Xiang‐ping Li
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 14871-14880 (2023)
Abstract Background Sintilimab combined with IBI305 treatment regimen had potential clinical benefits than sorafenib in the first‐line treatment of patients with unresectable hepatic cell carcinoma (HCC). However, whether sintilimab plus IBI305 has
Externí odkaz:
https://doaj.org/article/9c77064746284914a5d7bc99a6323257
Autor:
Zhuo‐Miao Ye, Zhe Xu, Hao‐Lun Wang, Ying‐Yuan Wang, Ze‐Chang Chen, Qin Zhou, Xiang‐Ping Li, Ying‐Ying Zhang
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 6182-6189 (2023)
Abstract Objective The KEYNOTE‐590 trial showed that individuals with advanced esophageal cancer who received Pembrolizumab in combination with chemotherapy as a first‐line regimen achieved a significant extension of survival. However, this treat
Externí odkaz:
https://doaj.org/article/1adb7162cb094c118a2b272a36928a5c
Autor:
Ke Liu, Jia-Jia Cui, Yan Zhan, Qian-Ying Ouyang, Qi-Si Lu, Dong-Hua Yang, Xiang-Ping Li, Ji-Ye Yin
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-23 (2022)
Abstract The tumor microenvironment (TME) is essential for immune escape by tumor cells. It plays essential roles in tumor development and metastasis. The clinical outcomes of tumors are often closely related to individual differences in the patient
Externí odkaz:
https://doaj.org/article/08d3e7f0fa294a1985c7d4335c29afa1
Autor:
Ting Zou, Jun-Yan Liu, Qun Qin, Jie Guo, Wen-Zhi Zhou, Xiang-Ping Li, Hong-Hao Zhou, Juan Chen, Zhao-Qian Liu
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3133 (2023)
Background: Lung cancer is still the most lethal malignancy in the world, according to the report of Cancer Statistics in 2021. Platinum-based chemotherapy combined with immunotherapy is the first-line treatment in lung cancer patients. However, the
Externí odkaz:
https://doaj.org/article/630db547cdcb4b88868f70de777885e6
Publikováno v:
Asian Journal of Andrology, Vol 24, Iss 3, Pp 311-316 (2022)
Repairing glans dehiscence after failed hypospadias repair is challenging for pediatric surgeons. Here, we introduced and evaluated a newly modified Mathieu technique, Mathieu combined tunnel (MCT), which involves multiple custom-designed flaps for t
Externí odkaz:
https://doaj.org/article/bd48d0f9ea9e487ebfc1514464831ac6
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
PURPOSE: To explore the relationship between ATM, ATR and CAT polymorphisms and prognosis of lung cancer patients received platinum-based chemotherapy.METHODS: 404 patients with lung cancer who received platinum-chemotherapy were enrolled and DNA typ
Externí odkaz:
https://doaj.org/article/c21b1ace6a654477ba6df9a1b483f093
Publikováno v:
Chinese Medicine, Vol 16, Iss 1, Pp 1-14 (2021)
Highlights Panax notoginseng saponins could be biotransformed to generate five main metabolites, including GF1, GRh2, GC-K, PPT and PPD, by human gut microbiota. Gut microbiota profiles were significantly different in high protein, high fat and low f
Externí odkaz:
https://doaj.org/article/789cdc3cdb9448dd81c891d46590e0a7
Autor:
Chao Fang, Yi-Xin Chen, Na-Yiyuan Wu, Ji-Ye Yin, Xiang-Ping Li, Hsuan-Shun Huang, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/cd99bd806e6c4876bc0906801c0df2c9
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Immunotherapy targeting programmed death ligand-1/programmed cell death protein-1 (PD-L1/PD-1) has achieved great success in multiple cancers, but only a small subset of patients showed clinical responses. Recent evidences have shown that post-transl
Externí odkaz:
https://doaj.org/article/58a729c9320146dd8f37380ba7798184